deltatrials
Completed INTERVENTIONAL NCT05886504

Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users (DRIVEMINDII)

DRIVE-Mind II (Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users) Impact of Sustained Psychiatric Intervention for People Who Inject Drugs on Their Viral Exposure and Mental Health in Haiphong, Vietnam

Sponsor: ANRS, Emerging Infectious Diseases

Updated 6 times since 2023 Last updated: Apr 10, 2026 Started: Mar 28, 2022 Primary completion: May 28, 2023 Completion: Jul 28, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Drug Use and Psychiatric Disorder and is currently completed. ANRS, Emerging Infectious Diseases leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Jul 2023 – ~Feb 2024 · 7 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshotActive Not Recruiting~Feb 2026 – ~Apr 2026 · 2 months · monthly snapshotUnknownApr 16, 2026 – present · 3 months · daily APICompleted

Change History

6 versions recorded
  1. Apr 16, 2026 — Present [daily]

    Completed

    Status: UnknownCompleted · Phase: NANone

  2. Feb 2026 — Apr 2026 [monthly]

    Unknown NA

    Status: Active Not RecruitingUnknown

  3. Sep 2024 — Feb 2026 [monthly]

    Active Not Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  5. Feb 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

Show 1 earlier version
  1. Jul 2023 — Feb 2024 [monthly]

    Recruiting NA

    First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

The main objective of this study is to show that People Who Inject Drugs (PWID) suffering initially from a major depressive disorder, a psychotic disorder and/or had a suicide risk and who received a community-based psychiatric intervention improve sustainably their mental health and are comparable after intervention to a population of PWID free of these disorders in terms of: * HIV/HCV exposure * Severity of substance use * Quality of life This is prospective one-year cohort study comparing 200 PWID diagnosed with a psychiatric disorder with 400 controls (200 PWID living with HIV and 200 PWID non-infected with HIV, both free of a diagnosis of depression, psychosis, suicidal risk at cohort initiation). Psychiatric intervention includes free psychiatric consultations and medications (issued on CBO sites), support from CBO members for appointments, information, treatment adherence, contact with families and tracing of those lost to follow-up. Target population and controls will also be proposed linkage to care (HIV, methadone) and harm reduction services.

Contact Information

Sponsor contact:
  • ANRS, Emerging Infectious Diseases
  • Center for supporting Community Developement Initiatives Hai Phong
  • Centre Pierre Nicole Croix-Rouge française
  • Haiphong University of Medicine and Pharmacy
  • Université Montpellier
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations